People · Operator
Named in public records as an officer, director or promoter · active 2010–2014 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nuon Therapeutics Inc | — | Biotechnology | Series A | $29.7M | $361.5M | 2010 |
| Pathway Therapeutics, Inc. | — | Biotechnology | Series A | $16.9M | $14.5M | 2011 |
| Spinifex Pharmaceuticals Inc | — | Pharmaceuticals | Series A | $6.2M | $191.0M | 2014 |
Joshua Funder at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joshua Funder on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Heath Lukatch | 1 | 10 |
| Robert More | 1 | 7 |
| Brent Ahrens | 1 | 7 |
| Mark Perry | 1 | 6 |
| Bob More | 1 | 6 |
| Declan Doogan | 1 | 6 |
| Kim Kamdar | 1 | 6 |
| Arlene Morris | 1 | 5 |
| Stephen Collins | 1 | 5 |
| Paul Goddard | 1 | 4 |
| Mark Harvey | 1 | 3 |
| Will Charles | 1 | 2 |
| Julie Cherrington | 1 | 2 |
| Tito Serafini | 1 | 2 |
| Helen Jenkins | 1 | 2 |
| Michael Kitt | 1 | 2 |
| Hillary Lewis | 1 | 1 |
| Rodney Pearlman | 1 | 1 |
| Josh Funder | 1 | 1 |
| Carrie Hillyard | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.